Close to three in four patients had trouble taking their GLP-1 consistently, and researchers say cost may be pushing people to quit early.
Recap by typeshit. Full story at ConsumerAffairs.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
The large study looked at people with both schizophrenia and diabetes taking drugs like Ozempic. Quartz notes the findings come with caveats.
At the Cambridge diabetes seminar in Kochi, Mithal faced Prof Bill Herman of the University of Michigan, with the audience joining in.
Loading…